Related references
Note: Only part of the references are listed.Homeobox B13 G84E Mutation and Prostate Cancer Risk
Tommy Nyberg et al.
EUROPEAN UROLOGY (2019)
Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017
Veda N. Giri et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean
Clarisse Joachim et al.
BMC CANCER (2018)
Computational Modeling of complete HOXB13 protein for predicting the functional effect of SNPs and the associated role in hereditary prostate cancer
Gopalakrishnan Chandrasekaran et al.
SCIENTIFIC REPORTS (2017)
Generalizability of established prostate cancer risk variants in men of African ancestry
Ying Han et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Identification of Two Novel HOXB13 Germline Mutations in Portuguese Prostate Cancer Patients
Sofia Maia et al.
PLOS ONE (2015)
A Population-based Assessment of Germline HOXB13 G84E Mutation and Prostate Cancer Risk
Robert Karlsson et al.
EUROPEAN UROLOGY (2014)
A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
Qilai Huang et al.
NATURE GENETICS (2014)
HOXB13 downregulates intracellular zinc and increases NF-κB signaling to promote prostate cancer metastasis
Y-R Kim et al.
ONCOGENE (2014)
HOXB13 G84E Mutation in Finland: Population-Based Analysis of Prostate, Breast, and Colorectal Cancer Risk
Virpi H. Laitinen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)
Jianfeng Xu et al.
HUMAN GENETICS (2013)
A novel Germline mutation in HOXB13 is associated with prostate cancer risk in Chinese men
Xiaoling Lin et al.
PROSTATE (2013)
Confirmation of the HOXB13 G84E Germline Mutation in Familial Prostate Cancer
Joan P. Breyer et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2012)
Association Between Germline HOXB13 G84E Mutation and Risk of Prostate Cancer
Mohammad R. Akbari et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Germline Mutations in HOXB13 and Prostate-Cancer Risk
Charles M. Ewing et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Prostate cancer epidemiology in the United States
Otis W. Brawley
WORLD JOURNAL OF UROLOGY (2012)
Chlordecone Exposure and Risk of Prostate Cancer
Luc Multigner et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
HOXB13 promotes ovarian cancer progression
Jiangyong Miao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the University of Michigan Prostate Cancer Genetics Project
SL Slager et al.
PROSTATE (2006)
HOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivation
C Jung et al.
BRITISH JOURNAL OF CANCER (2005)
HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling
C Jung et al.
CANCER RESEARCH (2004)
The multiethnic cohort study: Exploring genes, lifestyle and cancer risk
LN Kolonel et al.
NATURE REVIEWS CANCER (2004)
HLA class I and class II allele and haplotype diversity in Martinicans
O Bera et al.
TISSUE ANTIGENS (2001)